[go: up one dir, main page]

CL2017000178A1 - Compuestos para usar en el tratamiento antihelmíntico - Google Patents

Compuestos para usar en el tratamiento antihelmíntico

Info

Publication number
CL2017000178A1
CL2017000178A1 CL2017000178A CL2017000178A CL2017000178A1 CL 2017000178 A1 CL2017000178 A1 CL 2017000178A1 CL 2017000178 A CL2017000178 A CL 2017000178A CL 2017000178 A CL2017000178 A CL 2017000178A CL 2017000178 A1 CL2017000178 A1 CL 2017000178A1
Authority
CL
Chile
Prior art keywords
compounds
treatment
anthelmintic treatment
animals
disclosed
Prior art date
Application number
CL2017000178A
Other languages
English (en)
Inventor
Hans-Georg Schwarz
Ulrich Görgens
Claudia Welz
Adeline Köhler
Kirsten Börngen
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of CL2017000178A1 publication Critical patent/CL2017000178A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

<p>SE DIVULGAN COMPUESTOS DE LA FORMULA (I) QUE POSEEN PROPIEDADES ANTIHELMÍNTICAS, EN LA QUE LOS ELEMENTOS ESTRUCTURALES TIENEN EL SIGNIFICADO INDICADO EN LA DESCRIPCIÓN. ADEMÁS SE DIVULGAN TALES COMPUESTOS PARA EL CONTROL, EL TRATAMIENTO Y/O LA PREVENCIÓN DE LAS INFECCIONES CON HELMINTOS EN ANIMALES Y SERES HUMANOS.</p>
CL2017000178A 2014-07-25 2017-01-23 Compuestos para usar en el tratamiento antihelmíntico CL2017000178A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14178621 2014-07-25
EP15169965 2015-05-29

Publications (1)

Publication Number Publication Date
CL2017000178A1 true CL2017000178A1 (es) 2017-09-22

Family

ID=53610907

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000178A CL2017000178A1 (es) 2014-07-25 2017-01-23 Compuestos para usar en el tratamiento antihelmíntico

Country Status (14)

Country Link
US (1) US20170217931A1 (es)
EP (1) EP3172193A1 (es)
JP (1) JP2017521461A (es)
CN (1) CN107074803A (es)
AU (1) AU2015293966A1 (es)
BR (1) BR112017001384A2 (es)
CA (1) CA2955879A1 (es)
CL (1) CL2017000178A1 (es)
MX (1) MX2017001047A (es)
RU (1) RU2017105902A (es)
TW (1) TW201617330A (es)
UY (1) UY36196A (es)
WO (1) WO2016012485A1 (es)
ZA (1) ZA201701426B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2953467T3 (es) * 2016-04-15 2023-11-13 Elanco Animal Health Gmbh Derivados de pirazolopirimidina
WO2018165520A1 (en) 2017-03-10 2018-09-13 Vps-3, Inc. Metalloenzyme inhibitor compounds
PL3615527T3 (pl) * 2017-06-30 2024-07-01 Elanco Animal Health Gmbh Nowe pochodne azachinoliny
MX2020001403A (es) * 2017-08-04 2020-03-09 Bayer Animal Health Gmbh Nuevos derivados de quinolina.
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds
CA3149096A1 (en) 2019-07-30 2021-02-04 Eikonizo Therapapeutics, Inc. Hdac6 inhibitors and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI435863B (zh) 2006-03-20 2014-05-01 Nihon Nohyaku Co Ltd Ｎ-２-（雜）芳基乙基甲醯胺衍生物及含該衍生物之蟲害防治劑
MX2008015246A (es) 2006-06-08 2008-12-17 Syngenta Participations Ag Derivados de n-(1-alquil-2-feniletil)-carboxamida y uso de los mismos como fungicidas.
CA2682156C (en) 2007-04-12 2012-03-20 Nihon Nohyaku Co., Ltd. Nematicidal agent composition and method of using the same
WO2011020579A1 (de) 2009-08-20 2011-02-24 Bayer Cropscience Ag Verfahren zur herstellung von 1-phenyl-1,2,4-triazolen
CA2828060C (en) 2011-03-02 2018-11-06 The University Of Tokyo Endoparasite control agent
CN104023534A (zh) 2011-11-02 2014-09-03 拜耳知识产权有限责任公司 具有杀线虫活性的化合物
EP2773215A2 (en) 2011-11-02 2014-09-10 Bayer Intellectual Property GmbH Compounds with nematicidal activity
RU2014122450A (ru) 2011-11-04 2015-12-10 Зингента Партисипейшнс Аг Пестицидные соединения
JP2014532683A (ja) 2011-11-04 2014-12-08 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺虫化合物
EP2773622A1 (en) 2011-11-04 2014-09-10 Syngenta Participations AG Pesticidal compounds
US8987465B2 (en) 2011-11-04 2015-03-24 Syngenta Participation Ag Pesticidal compounds
MX349802B (es) 2011-11-25 2017-08-14 Bayer Ip Gmbh Uso de aril- y hetarilcarboxamidas como endoparasiticidas.
TWI654180B (zh) * 2012-06-29 2019-03-21 美商艾佛艾姆希公司 殺真菌之雜環羧醯胺
CN104582696B (zh) 2012-08-30 2018-07-03 国立大学法人东京大学 体内寄生虫防治剂及其使用方法
CN104582702B (zh) 2012-08-30 2018-07-10 国立大学法人东京大学 体内寄生虫防治剂
AR097423A1 (es) * 2013-08-26 2016-03-16 Bayer Cropscience Ag Compuestos con actividad plaguicida

Also Published As

Publication number Publication date
MX2017001047A (es) 2017-10-12
UY36196A (es) 2016-02-29
CA2955879A1 (en) 2016-01-28
WO2016012485A1 (en) 2016-01-28
EP3172193A1 (en) 2017-05-31
AU2015293966A1 (en) 2017-02-02
CN107074803A (zh) 2017-08-18
JP2017521461A (ja) 2017-08-03
ZA201701426B (en) 2018-12-19
RU2017105902A (ru) 2018-08-27
US20170217931A1 (en) 2017-08-03
TW201617330A (zh) 2016-05-16
BR112017001384A2 (pt) 2018-06-05

Similar Documents

Publication Publication Date Title
CL2018001685A1 (es) Compuestos heterociclicos como inmuno moduladores.
ECSP19003773A (es) Compuestos heterocíclicos como inmunomoduladores
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
CL2017000178A1 (es) Compuestos para usar en el tratamiento antihelmíntico
MX382671B (es) Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington
CO2017004525A2 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
CL2017001025A1 (es) Compuestos para usarse en el tratamiento antihelmíntico
CR20160456A (es) Compuestos de heteroarilo o arilo bibíclicos fusionados
DK3297637T3 (da) Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf
MX2017002670A (es) Inhibidores de glucosidasa.
MX2018000511A (es) Derivados de fenoximetilo.
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
MX2018010993A (es) Derivados de icariina e icaritina.
CR20150648A (es) Derivados de nucleósido 4´-azido, 3´-desoxi-3´-fluoro sustituido
CO2017005038A2 (es) Composicones y métodos de tratamiento con profármacos de tizoxanida, un análogo o sal de la misma
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
EP3310376A4 (en) MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
MX2019006893A (es) Inhibidores heterociclicos de mct4.
MX395231B (es) Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de hígado graso, y uso de los mismos.
IL268728A (en) Formulations of cannabinoids for the treatment of acne
UY35274A (es) Compuestos y métodos para tratar infecciones bacterianas
DOP2016000170A (es) Compuestos derivados de hidroxiformamida y usos del mismo
CR20150649A (es) Derivados de nucleósidos 4´-azido,3´-desoxi-3´-fluoro sustituido
MX2016014859A (es) Composiciones farmaceuticas que comprenden danirixina para tratar enfermedades infecciosas.
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas